Newsletter
Trump signs hemp product ban delay (Newsletter: September 4, 2026)
ID lawmaker: Vote for anti-marijuana ballot measure; Study: Cannabis in dentistry; Future of hemp op-ed
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today.
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
President Donald Trump signed a bill containing provisions to delay the federal recriminalization of hemp THC products, giving lawmakers more time to craft regulations as an alternative to prohibition.
An Idaho senator is urging voters to approve a proposed constitutional initiative on the November ballot to make it so marijuana could only be legalized in the future by an act of the legislature and not via a voter initiative.
- “The reason that people push this—the marijuana lobby, whomever—is because there’s money to be made, particularly when people become addicted.”
A new scientific review concluded that “cannabis has promising therapeutic potential in dentistry, with its main applications in the management of orofacial pain, periodontics, burning mouth syndrome, bruxism, management of oral mucositis, among others.”
- “Integrating cannabinoids into dental practice represents a significant path toward improving clinical outcomes and enhancing patients’ quality of life during treatments.”
- “The coming weeks will show whether the one-month reprieve becomes a bridge to lasting regulatory clarity or simply a brief postponement of an existential deadline.”
/ FEDERAL
Drug Enforcement Administration Administrator Terrance Cole reportedly failed to properly disclose hundreds of thousands of dollars’ worth of personal stock purchases.
The U.S. Embassy & Consulates in Canada posted a warning that “it is illegal to bring cannabis across the border, including products such as edible cannabis, cannabis extracts, and items containing CBD.”
/ STATES
A former Pennsylvania representative is lobbying for the cannabis company Cresco Labs.
Missouri regulators announced a recall of marijuana products that contain cannabinoids produced through chemical modification, conversion, or synthetic derivation.
California regulators rescinded a recall of marijuana products after further investigation confirmed that regulatory compliance testing was properly completed.
Michigan regulators published an updated marijuana business compliance best practices guide.
The Oregon Department of Transportation included an increase in cannabis taxes in an analysis of potential ways to raise revenue.
Montana regulators sent a newsletter with updates on various cannabis issues.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The San Diego County, California Board of Supervisors voted to allow expanded marijuana business operations in unincorporated areas.
/ INTERNATIONAL
Ghana’s Narcotics Control Commission is collaborating on low-THC cannabis research.
/ SCIENCE & HEALTH
A study “found evidence that cannabis use was associated with reduced alcohol use.”
A study of rats found that “CBDA has anti-inflammatory properties by reducing the synthesis of lipid inflammatory mediators, which are concomitant with improved insulin signaling and probably reduced neurodegeneration,” suggesting that it “could be considered as a part of future clinical treatment for many inflammatory conditions.”
/ BUSINESS
cbdMD, Inc. is acquiring Twinlab.
New England Treatment Access workers in Franklin, Massachusetts approved a new contract.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Mike Latimer.
